Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patients initiating medication-assisted treatment

The purpose of this research study is to examine the impact of medications (methadone, buprenorphine, or extended-release naltrexone) used to treat opioid use disorder on the immune system — the body’s ability to fight infection. The study will try to find out how these opioid treatment medications affect immune function. This is an important question for people living with HIV infection because HIV weakens the immune system.

You may be eligible for this study if you meet the following criteria:

• Conditions:
  HIV
• Age: Between 18 Years - 70 Years
• Gender: All